Post-ERCP pancreatitis: still a major issue despite all efforts

Endoscopy 2021; 53(04): 367-368
DOI: 10.1055/a-1369-9031

Editorial

Referring to Mutneja H et al. p. 357–366

Jacques Devière

Gastroenterology, Hepatopancreatology, and Digestive Oncology, Erasme University Hospital, Brussels, Belgium

References
1 Dumonceau J-M, Andriulli A, Elmunzer BJ. et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline – updated June 2014. Endoscopy 2014; 46: 799-815
2 Freeman ML, Nelson DB, Sherman S. et al. Complications of endoscopic biliary sphincterotomy. New Engl J Med 1996; 335: 909-918
3 Lee HJ, Cho CM, Heo J. et al. Impact of hospital volume and the experience of endoscopist on adverse events related to endoscopic retrograde cholangiopancreatography: a prospective observational study. Gut Liver 2020; 14: 257-264
4 Andriulli A, Loperfido S, Napolitano G. et al. Incidence rates of post-ERCP complications. Am J Gastroenterol 2007; 102: 1781-1788
5 Park CH, Paik WH, Park FT. et al. Aggressive intravenous hydration with lactated Ringer’s solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial. Endoscopy 2018; 50: 378-385
6 Mutneja HR, Vohra I, Go A. et al. Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysis. Endoscopy 2021; 53: 357-366
7 Chandrasekhara V, Khashab MA. ASGE Standards of Practice Committee. et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
8 Dumonceau JM, Rigaux J, Kahaleh M. et al. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc 2010; 71: 934-939